Ricardo T. Gazzinelli

30.9k total citations · 9 hit papers
331 papers, 23.9k citations indexed

About

Ricardo T. Gazzinelli is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Ricardo T. Gazzinelli has authored 331 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Epidemiology, 166 papers in Public Health, Environmental and Occupational Health and 141 papers in Immunology. Recurrent topics in Ricardo T. Gazzinelli's work include Trypanosoma species research and implications (147 papers), Research on Leishmaniasis Studies (133 papers) and Toxoplasma gondii Research Studies (82 papers). Ricardo T. Gazzinelli is often cited by papers focused on Trypanosoma species research and implications (147 papers), Research on Leishmaniasis Studies (133 papers) and Toxoplasma gondii Research Studies (82 papers). Ricardo T. Gazzinelli collaborates with scholars based in Brazil, United States and United Kingdom. Ricardo T. Gazzinelli's co-authors include Alan Sher, Sara Hieny, Eric Denkers, Isabelle P. Oswald, Stephanie L. James, Catherine Ropert, Douglas T. Golenbock, Igor C. Almeida, João S. Silva and Thomas A. Wynn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ricardo T. Gazzinelli

324 papers receiving 23.5k citations

Hit Papers

Interleukin 12 acts directly on CD4+ T cells to enhance p... 1991 2026 2002 2014 1993 1996 1993 1992 1994 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo T. Gazzinelli Brazil 78 12.6k 9.8k 8.4k 8.3k 3.6k 331 23.9k
Victor Nussenzweig United States 89 5.6k 0.4× 12.0k 1.2× 2.8k 0.3× 10.4k 1.2× 8.0k 2.2× 303 26.0k
Louis M. Weiss United States 68 8.0k 0.6× 1.7k 0.2× 11.8k 1.4× 2.9k 0.4× 3.7k 1.0× 388 18.7k
L. David Sibley United States 96 14.3k 1.1× 3.6k 0.4× 20.1k 2.4× 3.6k 0.4× 4.7k 1.3× 286 25.9k
John C. Boothroyd United States 87 12.4k 1.0× 2.3k 0.2× 15.0k 1.8× 3.5k 0.4× 5.1k 1.4× 240 20.8k
Jack S. Remington United States 86 14.6k 1.2× 4.6k 0.5× 16.5k 2.0× 2.9k 0.3× 2.9k 0.8× 370 25.6k
Alan Sher United States 122 16.5k 1.3× 29.2k 3.0× 16.0k 1.9× 6.9k 0.8× 9.8k 2.7× 449 57.2k
A Capron France 73 3.3k 0.3× 5.5k 0.6× 9.3k 1.1× 3.5k 0.4× 3.3k 0.9× 598 21.4k
David L. Sacks United States 86 11.5k 0.9× 7.7k 0.8× 3.8k 0.5× 16.1k 1.9× 2.6k 0.7× 209 22.1k
Robert W. Sauerwein Netherlands 77 2.3k 0.2× 6.0k 0.6× 3.2k 0.4× 14.4k 1.7× 3.5k 1.0× 366 19.8k
Louis H. Miller United States 85 2.8k 0.2× 11.6k 1.2× 3.6k 0.4× 19.5k 2.3× 5.9k 1.6× 325 27.5k

Countries citing papers authored by Ricardo T. Gazzinelli

Since Specialization
Citations

This map shows the geographic impact of Ricardo T. Gazzinelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo T. Gazzinelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo T. Gazzinelli more than expected).

Fields of papers citing papers by Ricardo T. Gazzinelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo T. Gazzinelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo T. Gazzinelli. The network helps show where Ricardo T. Gazzinelli may publish in the future.

Co-authorship network of co-authors of Ricardo T. Gazzinelli

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo T. Gazzinelli. A scholar is included among the top collaborators of Ricardo T. Gazzinelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo T. Gazzinelli. Ricardo T. Gazzinelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pereira, Milton, Juliana de Oliveira Silva, Natália Satchiko Hojo-Souza, et al.. (2025). The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens. Journal of Nanobiotechnology. 23(1). 221–221. 2 indexed citations
2.
Oliveira, José Luís, Ségolène Brichler, Juan Miguel Villalobos Salcêdo, et al.. (2025). A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. Journal of Clinical Microbiology. 63(5). e0199924–e0199924. 3 indexed citations
3.
Teixeira, Santuza Maria Ribeiro, et al.. (2025). The time has come for a vaccine against Chagas disease. The Lancet Regional Health - Americas. 45. 101059–101059. 1 indexed citations
4.
Kano, Flora Satiko, Pedro Augusto Alves, Marco Antônio Campos, et al.. (2024). Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections. npj Vaccines. 9(1). 246–246. 1 indexed citations
5.
Figueiredo, Maria Marta, Pedro Augusto Carvalho Costa, Olindo Assis Martins‐Filho, et al.. (2023). Adenosine pathway regulates inflammation during Plasmodium vivax infection. Frontiers in Immunology. 14. 1193256–1193256. 1 indexed citations
6.
Hojo-Souza, Natália Satchiko, Flávio Guimarães da Fonseca, Santuza Maria Ribeiro Teixeira, et al.. (2023). Quality Attributes of Ctvad1, A Nanoemulsified Adjuvant for Phase I Clinical Trial of SpiN COVID-19 Vaccine. Nanomedicine. 18(18). 1175–1194. 1 indexed citations
7.
Parise, Pierina Lorencini, Daniel A. Toledo-Teixeira, Ricardo T. Gazzinelli, et al.. (2022). Previous Infection with SARS-CoV-2 Correlates with Increased Protective Humoral Responses after a Single Dose of an Inactivated COVID-19 Vaccine. Viruses. 14(3). 510–510. 6 indexed citations
8.
Yasunaga, Ari, et al.. (2022). Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival. iScience. 25(9). 104909–104909. 3 indexed citations
9.
Hojo-Souza, Natália Satchiko, Patrick O. Azevedo, Andréa Teixeira‐Carvalho, et al.. (2020). Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage. PLoS Pathogens. 16(9). e1008840–e1008840. 16 indexed citations
10.
Figueiredo, Maria Marta, Lara Carvalho Godói, Andreza Pain Marcelino, et al.. (2019). Evaluation of three recombinant proteins for the development of ELISA and immunochromatographic tests for visceral leishmaniasis serodiagnosis. Memórias do Instituto Oswaldo Cruz. 114. 10 indexed citations
11.
Chen, Yongzhi, Shruti Sharma, Patrícia A. Assis, et al.. (2018). CNBP controls IL-12 gene transcription and Th1 immunity. The Journal of Experimental Medicine. 215(12). 3136–3150. 28 indexed citations
12.
Schrum, Jacob, Juliet Crabtree, Katherine R. Dobbs, et al.. (2018). Cutting Edge: Plasmodium falciparum Induces Trained Innate Immunity. The Journal of Immunology. 200(4). 1243–1248. 101 indexed citations
13.
Vasconcelos, José Ronnie, Mariana R. Dominguez, Jonatan Ersching, et al.. (2014). Adenovirus Vector-Induced CD8 + T Effector Memory Cell Differentiation and Recirculation, But Not Proliferation, Are Important for Protective Immunity Against Experimental Trypanosoma cruzi Infection. Human Gene Therapy. 25(4). 350–363. 21 indexed citations
14.
Vasconcelos, José Ronnie, Oscar Bruña–Romero, Adriano Fernando Araújo, et al.. (2012). Pathogen-Induced Proapoptotic Phenotype and High CD95 (Fas) Expression Accompany a Suboptimal CD8+ T-Cell Response: Reversal by Adenoviral Vaccine. PLoS Pathogens. 8(5). e1002699–e1002699. 50 indexed citations
15.
Parroche, Peggy, Fanny N. Lauw, Nadège Goutagny, et al.. (2007). Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proceedings of the National Academy of Sciences. 104(6). 1919–1924. 426 indexed citations
16.
Yamauchi, Lucy Megumi, Júlio Aliberti, Marcelo Dias‐Baruffi, et al.. (2006). The binding of CCL2 to the surface of Trypanosoma cruzi induces chemo-attraction and morphogenesis. Microbes and Infection. 9(1). 111–118. 10 indexed citations
17.
Khatri, Vijay P., Todd A. Fehniger, Robert A. Baiocchi, et al.. (1998). Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.. Journal of Clinical Investigation. 101(6). 1373–1378. 50 indexed citations
18.
Gazzinelli, Ricardo T., Nathalia A. Giese, & Herbert C. Morse. (1994). In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS).. The Journal of Experimental Medicine. 180(6). 2199–2208. 94 indexed citations
19.
Gazzinelli, Ricardo T., Maria Wysocka, Seiji Hayashi, et al.. (1994). Parasite-induced IL-12 stimulates early IFN- gamma synthesis and resistance during acute infection with Toxoplasma gondii .. The Journal of Immunology. 153(6). 2533–2543. 588 indexed citations breakdown →
20.
Brindley, Paul J., Ricardo T. Gazzinelli, Eric Denkers, et al.. (1993). Differentiation of Toxoplasma Gondii from Closely Related Coccidia by Riboprint Analysis and a Surface Antigen Gene Polymerase Chain Reaction. American Journal of Tropical Medicine and Hygiene. 48(3). 447–456. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026